JPH04234804A - Hair restorer - Google Patents
Hair restorerInfo
- Publication number
- JPH04234804A JPH04234804A JP3094685A JP9468591A JPH04234804A JP H04234804 A JPH04234804 A JP H04234804A JP 3094685 A JP3094685 A JP 3094685A JP 9468591 A JP9468591 A JP 9468591A JP H04234804 A JPH04234804 A JP H04234804A
- Authority
- JP
- Japan
- Prior art keywords
- group
- acid
- hair growth
- hair restorer
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004209 hair Anatomy 0.000 title abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 4
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 4
- 229930195734 saturated hydrocarbon Natural products 0.000 claims abstract description 4
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims abstract description 4
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 230000007794 irritation Effects 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 abstract description 26
- 229960003237 betaine Drugs 0.000 abstract description 13
- 150000001875 compounds Chemical class 0.000 abstract description 7
- 206010040880 Skin irritation Diseases 0.000 abstract description 4
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 abstract description 4
- 229960001067 hydrocortisone acetate Drugs 0.000 abstract description 4
- 230000036556 skin irritation Effects 0.000 abstract description 4
- 231100000475 skin irritation Toxicity 0.000 abstract description 4
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 abstract description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 abstract description 3
- 235000019410 glycyrrhizin Nutrition 0.000 abstract description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 3
- 201000004384 Alopecia Diseases 0.000 abstract description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract description 2
- 102000016943 Muramidase Human genes 0.000 abstract description 2
- 108010014251 Muramidase Proteins 0.000 abstract description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 abstract description 2
- 231100000360 alopecia Toxicity 0.000 abstract description 2
- IHSPMDXQWYKHOA-UHFFFAOYSA-N dodecyl 2-(dimethylamino)acetate Chemical compound CCCCCCCCCCCCOC(=O)CN(C)C IHSPMDXQWYKHOA-UHFFFAOYSA-N 0.000 abstract description 2
- 235000010335 lysozyme Nutrition 0.000 abstract description 2
- 239000004325 lysozyme Substances 0.000 abstract description 2
- 229960000274 lysozyme Drugs 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 230000003779 hair growth Effects 0.000 description 20
- -1 hexadecenyl group Chemical group 0.000 description 17
- 239000000203 mixture Substances 0.000 description 12
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 11
- 239000008213 purified water Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 6
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 6
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 6
- 229940032094 squalane Drugs 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 3
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Chemical class C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 3
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229960000458 allantoin Drugs 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 3
- 229960003720 enoxolone Drugs 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 235000019271 petrolatum Nutrition 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 239000003871 white petrolatum Substances 0.000 description 3
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 2
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 2
- XCTDECJAHGTSBU-UHFFFAOYSA-N 2-(dimethylamino)docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCC(N(C)C)C(O)=O XCTDECJAHGTSBU-UHFFFAOYSA-N 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 241001071917 Lithospermum Species 0.000 description 2
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- FPVRUILUEYSIMD-RPRRAYFGSA-N [(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(OC(C)=O)[C@@]1(C)C[C@@H]2O FPVRUILUEYSIMD-RPRRAYFGSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 2
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229960003657 dexamethasone acetate Drugs 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- BHCBQALBZYVPNR-UHFFFAOYSA-N dodecyl 2-amino-2-methylpropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)(C)N BHCBQALBZYVPNR-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229960003399 estrone Drugs 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229960001680 ibuprofen Drugs 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229960003517 isothipendyl Drugs 0.000 description 2
- OQJBSDFFQWMKBQ-UHFFFAOYSA-N isothipendyl Chemical group C1=CN=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 OQJBSDFFQWMKBQ-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- YQACAXHKQZCEOI-UDCWSGSHSA-N (8s,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-17-carboxylic acid Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(O)=O)[C@@H]4[C@@H]3CCC2=C1 YQACAXHKQZCEOI-UDCWSGSHSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DBPWSSGDRRHUNT-UHFFFAOYSA-N 17alpha-hydroxy progesterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)(O)C1(C)CC2 DBPWSSGDRRHUNT-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- BKUWWVKLLKXDJK-UHFFFAOYSA-N 2-(dimethylamino)icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(N(C)C)C(O)=O BKUWWVKLLKXDJK-UHFFFAOYSA-N 0.000 description 1
- XQXCSIXQJDKACR-UHFFFAOYSA-N 2-(dimethylamino)octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(N(C)C)C(O)=O XQXCSIXQJDKACR-UHFFFAOYSA-N 0.000 description 1
- UNIKQYIJSJGRRS-UHFFFAOYSA-N 2-(dimethylazaniumyl)butanoate Chemical compound CCC(N(C)C)C(O)=O UNIKQYIJSJGRRS-UHFFFAOYSA-N 0.000 description 1
- IYVVKFYDGRJWTR-UHFFFAOYSA-N 2-decanoylglycerol Chemical compound CCCCCCCCCC(=O)OC(CO)CO IYVVKFYDGRJWTR-UHFFFAOYSA-N 0.000 description 1
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- XUGISPSHIFXEHZ-UHFFFAOYSA-N 3beta-acetoxy-cholest-5-ene Natural products C1C=C2CC(OC(C)=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 XUGISPSHIFXEHZ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- BHYOQNUELFTYRT-UHFFFAOYSA-N Cholesterol sulfate Natural products C1C=C2CC(OS(O)(=O)=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 BHYOQNUELFTYRT-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DOMWKUIIPQCAJU-LJHIYBGHSA-N Hydroxyprogesterone caproate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)CCCCC)[C@@]1(C)CC2 DOMWKUIIPQCAJU-LJHIYBGHSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- AVTXVDFKYBVTKR-DPAQBDIFSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] dihydrogen phosphate Chemical compound C1C=C2C[C@@H](OP(O)(O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 AVTXVDFKYBVTKR-DPAQBDIFSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 108010027597 alpha-chymotrypsin Proteins 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 229960004311 betamethasone valerate Drugs 0.000 description 1
- SNHRLVCMMWUAJD-SUYDQAKGSA-N betamethasone valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 125000003901 ceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- BHYOQNUELFTYRT-DPAQBDIFSA-N cholesterol sulfate Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 BHYOQNUELFTYRT-DPAQBDIFSA-N 0.000 description 1
- XUGISPSHIFXEHZ-VEVYEIKRSA-N cholesteryl acetate Chemical compound C1C=C2C[C@@H](OC(C)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 XUGISPSHIFXEHZ-VEVYEIKRSA-N 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- IVHBBMHQKZBJEU-UHFFFAOYSA-N cinchocaine hydrochloride Chemical compound [Cl-].C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCC[NH+](CC)CC)=C21 IVHBBMHQKZBJEU-UHFFFAOYSA-N 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 1
- 229960000978 cyproterone acetate Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PEMXEBAGWQVTLH-UHFFFAOYSA-N decyl 2-(dimethylamino)acetate Chemical compound CCCCCCCCCCOC(=O)CN(C)C PEMXEBAGWQVTLH-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960001378 dequalinium chloride Drugs 0.000 description 1
- LTNZEXKYNRNOGT-UHFFFAOYSA-N dequalinium chloride Chemical compound [Cl-].[Cl-].C1=CC=C2[N+](CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)=C(C)C=C(N)C2=C1 LTNZEXKYNRNOGT-UHFFFAOYSA-N 0.000 description 1
- 229940045574 dibucaine hydrochloride Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- RBHFPIHDGCGQPN-UHFFFAOYSA-N ethyl 3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound C1=C(C(C)C)C=CC(C)=C2C(S(=O)(=O)OCC)=CC(C)=C21 RBHFPIHDGCGQPN-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229950000801 hydroxyprogesterone caproate Drugs 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 125000002463 lignoceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000810 peripheral vasodilating agent Substances 0.000 description 1
- 229960002116 peripheral vasodilator Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229960000581 salicylamide Drugs 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229950002760 sodium gualenate Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- GEYJUFBPCGDENK-UHFFFAOYSA-M sodium;3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound [Na+].CC(C)C1=CC=C(C)C2=C(S([O-])(=O)=O)C=C(C)C2=C1 GEYJUFBPCGDENK-UHFFFAOYSA-M 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 125000005063 tetradecenyl group Chemical group C(=CCCCCCCCCCCCC)* 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Abstract
Description
【0001】0001
【産業上の利用分野】本発明はアルキルカルボキシベタ
イン又はその塩及び刺激緩和剤を配合した、皮膚刺激性
の低い発毛剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hair growth agent with low skin irritation, which contains an alkylcarboxybetaine or a salt thereof and an irritation reliever.
【0002】0002
【従来の技術】従来、養毛剤、育毛剤、発毛剤としては
塩化カルプロニウム、エストラジオール、シュエルチア
マリン、ペンタデカン酸グリセリド、人参エキスなどが
用いられてきたが、その効果はいずれも十分ではなく、
脱毛症を著しく改善することはできなかった。[Prior Art] Conventionally, carpronium chloride, estradiol, schwertiamarin, pentadecanoic acid glyceride, and ginseng extract have been used as hair tonics, hair growth agents, and hair growth agents, but none of them are sufficiently effective.
It was not possible to significantly improve alopecia.
【0003】このような状況の中で本発明者らはUnder these circumstances, the present inventors
【00
04】00
04]
【化2】[Case 2]
【0005】(化2中、R1は炭素原子数6〜26の飽
和又は不飽和炭化水素の1価の基を示し、R2及びR3
は水素原子又は低級アルキル基を示し、Aは「メチル基
又は水酸基」で置換されていてもよい炭素原子数1〜3
のアルキレン基を示す。)で表されるアルキルカルボキ
シベタイン及びその塩に優れた発毛作用があることを見
いだした。(In formula 2, R1 represents a monovalent group of saturated or unsaturated hydrocarbon having 6 to 26 carbon atoms, and R2 and R3
represents a hydrogen atom or a lower alkyl group, and A has 1 to 3 carbon atoms, which may be substituted with a "methyl group or hydroxyl group"
represents an alkylene group. ) and its salts have been found to have excellent hair growth effects.
【0006】[0006]
【発明が解決しようとする課題】しかしながら、化2の
化合物には皮膚刺激性があるので、この点を改善した製
剤を開発することがより好ましかった。[Problems to be Solved by the Invention] However, since the compound of Chemical Formula 2 has skin irritation properties, it was more desirable to develop a formulation that improves this point.
【0007】[0007]
【課題を解決するための手段】本発明者らは優れた発毛
作用を有する化2の化合物を活用して、優れた発毛作用
を有し、しかも皮膚刺激性の低い発毛剤を得るべく鋭意
研究の結果、化2の化合物とある特定の刺激緩和剤を配
合した発毛剤が目的を達成することを見いだし、本発明
を完成した。[Means for Solving the Problems] The present inventors utilize the compound of chemical formula 2 that has an excellent hair growth effect to obtain a hair growth agent that has an excellent hair growth effect and is less irritating to the skin. As a result of intensive research, it was discovered that a hair growth agent containing the compound of chemical formula 2 and a certain irritation-reducing agent could achieve the objective, and the present invention was completed.
【0008】すなわち、本発明は化2の化合物又はその
塩及び刺激緩和剤を配合した発毛剤である。That is, the present invention is a hair growth agent containing the compound of formula 2 or a salt thereof and an irritation reliever.
【0009】以下、本発明を詳細に説明する。本発明に
おいて、炭素原子数6〜26の飽和又は不飽和炭化水素
の1価の基とはヘキシル基、ヘプチル基、オクチル基、
ノニル基、デシル基、ウンデシル基、ドデシル基、テト
ラデシル基、ベンタデシル基、ヘキサデシル基、オクタ
デシル基、イコシル基、テトラコシル基、ヘキサコシル
基、ヘキセニル基、デセニル基、テトラデセニル基、ヘ
キサデセニル基、オクタデカジエニル基などであり、直
鎖状でも、分岐していても、環状でもよい。また、低級
アルキル基とはメチル基、エチル基、プロピル基、ブチ
ル基などであり、直鎖状でもゝ分枝鎖状でもよい。The present invention will be explained in detail below. In the present invention, monovalent groups of saturated or unsaturated hydrocarbons having 6 to 26 carbon atoms include hexyl group, heptyl group, octyl group,
Nonyl group, decyl group, undecyl group, dodecyl group, tetradecyl group, bentadecyl group, hexadecyl group, octadecyl group, icosyl group, tetracosyl group, hexacosyl group, hexenyl group, decenyl group, tetradecenyl group, hexadecenyl group, octadecadienyl group etc., and may be linear, branched, or cyclic. Further, the lower alkyl group includes a methyl group, an ethyl group, a propyl group, a butyl group, etc., and may be linear or branched.
【0010】刺激緩和剤としてはグリチルリチン酸又は
その誘導体[例えばグリチルリチン酸の塩(グリチルリ
チン酸ジカリウムなどのアルカリ金属塩、アンモニウム
塩、アルカノールアミン塩、塩基性アミノ酸塩、ピリド
レチンなど)、グリチルレチン酸、グリチルレチン酸ス
テアリル、3−ステアリルオキシグリチルレチン酸、3
−サクシニルオキシグリチルレチン酸ジナトリウムなど
]、酢酸ハイドロコーチゾン、酢酸デキサメサゾン、吉
草酸ベタメタゾン、トリアムシノロンアセトニド、α−
キモトリプシン、塩化リゾチーム、塩化ベルベリン、シ
コニン、サリチル酸、アセチルサリチル酸、サリチル酸
アミド、グアイアズレン、グアイアズレンスルホン酸ナ
トリウム、グアイアズレンスルホン酸エチル、トラネキ
サム酸、インドメタシン、ヒノキチオール、コレスタノ
ール、コレスタノールホスフェート、イブプロフェン、
ケトプロフェン、フルビプロフェン、イプシロンアミノ
カプロン酸、コレステロール、コレステロールアセテー
ト、コレステロールステアリル、コレステロールサルフ
ェート、コレステロールホスフェート、O−アシルセラ
ミド、動物由来ケラチンあるいはそれらの加水分解物、
ジフェンヒドラミン、イソチペンジル、アラントイン、
アラントインクロルヒドロキシアルミニウム、アラント
イン−dl−バントテニルアルコールなどが挙げられる
。As irritation relievers, glycyrrhizic acid or its derivatives [for example, salts of glycyrrhizic acid (alkali metal salts such as dipotassium glycyrrhizinate, ammonium salts, alkanolamine salts, basic amino acid salts, pyridretin, etc.), glycyrrhetinic acid, glycyrrhetinic acid, etc. Stearyl, 3-stearyloxyglycyrrhetinic acid, 3
- disodium succinyloxyglycyrrhetinate, etc.], hydrocortisone acetate, dexamethasone acetate, betamethasone valerate, triamcinolone acetonide, α-
Chymotrypsin, lysozyme chloride, berberine chloride, shikonin, salicylic acid, acetylsalicylic acid, salicylic acid amide, guaiazulene, sodium guaiazulene sulfonate, ethyl guaiazulene sulfonate, tranexamic acid, indomethacin, hinokitiol, cholestanol, cholestanol phosphate, ibuprofen,
Ketoprofen, flubiprofen, epsilon aminocaproic acid, cholesterol, cholesterol acetate, cholesterol stearyl, cholesterol sulfate, cholesterol phosphate, O-acylceramide, animal-derived keratin or their hydrolysates,
diphenhydramine, isothipendyl, allantoin,
Examples include allantoin chlorohydroxyaluminum, allantoin-dl-bantothenyl alcohol, and the like.
【0011】本発明の発毛剤は、有効成分として化2の
化合物又はその塩の1種を用いてもよいし、2種以上を
用いてもよい。有効成分の配合量は、製剤全量の0.1
〜40重量%であり、好ましくは0.5〜5重量%であ
る。また、刺激緩和剤の配合量は、化2の化合物の配合
量によって変わるが、概ね0.001〜20重量%、好
ましくは0.01〜10重量%である。[0011] The hair growth agent of the present invention may use one type of compound of formula 2 or a salt thereof, or two or more types thereof as an active ingredient. The amount of active ingredient is 0.1 of the total amount of the preparation.
-40% by weight, preferably 0.5-5% by weight. Further, the amount of the irritation-reducing agent varies depending on the amount of the compound of Chemical Formula 2, but is generally 0.001 to 20% by weight, preferably 0.01 to 10% by weight.
【0012】本発明の発毛剤は通常用いられる方法(例
えば、第11改正日本薬局方に規定する方法)に従って
、ローション、乳液、クリーム、ゲル、エアゾールなど
の各種の剤形に調製することができる。The hair growth agent of the present invention can be prepared into various dosage forms such as lotions, milky lotions, creams, gels, and aerosols according to commonly used methods (for example, methods specified in the 11th edition of the Japanese Pharmacopoeia). can.
【0013】本発明の発毛剤は、前記必須成分の他、通
常発毛剤に用いられる物質、例えば保湿剤(ブロビレン
グリコール、グリセリン、ジグリセリンなど)、溶媒(
エチルアルコール、イソプロビルアルコール、1,3−
ブチレングリコール、精製水など)、保存剤(バラベン
、安息香酸など)、ビタミン類(ビタミンA、ビタミン
B、ビタミンC、ビタミンD、ビタミンEなど)、油分
(流動パラフィン、セチルアルコール、ステアリルアル
コール、スクワラン、白色ワセリン、オリーブ油など)
、殺菌剤[硫黄、グルコン酸クロルヘキシジン、塩酸ク
ロルヘキシジン、イソプロピルメチルフェノール、第4
級アンモニウム塩(例えば塩化ベンザルコニウムなど)
、塩化デカリニウム、ヒノキチオールなど]、非イオン
性界面活性剤(ポリオキシエチレン脂肪酸エステル、ポ
リオキシエチレンソルビタン脂肪酸エステル、ソルビタ
ン脂肪酸エステル、グリセリンモノ脂肪酸エステル、ポ
リオキシエチレン硬化ヒマシ油誘導体など)、増粘剤(
ポリビニルビロリドン、カルボキシメチルセルロース、
カルボキシエチルセルロース、ヒドロキシプロビルセル
ロース、カルボキシビニルポリマーなど)、pH調整剤
(ジイソプロパノールアミン、クエン酸など)、酸化防
止剤(ジブチルヒドロキシトルエン、亜硫酸水素ナトリ
ウムなど)、清涼化剤(1−メントール、カンフルなど
)ゝ末梢血管拡張剤(酢酸トロフェロール、ニコチン酸
ベンジル、シュエルチアマリン、トウガラシエキス、カ
ブサイシンなど)、局所麻酔剤(塩酸ジブカイン、塩酸
リドカインなど)、角質溶解剤(尿素、サリチル酸など
)、卵胞ホルモン(17β−エストラジオール、エスト
ロンなど)、黄体ホルモン(プロゲステロン、17α−
ヒドロキシプロゲステロンなど)、副腎皮質ホルモン(
酢酸デキサメサゾン、酢酸ハイドロコーチゾンなど)、
抗ヒスタミン剤(塩酸ジフェンヒドラミン、塩酸イソチ
ペンジルなど)、抗アンドロゲン剤(シプロテロンアセ
テート、4−アンドロステン−3−オン−17β−カル
ボキシリックアシッドなど)、香料、金属イオン封鎖剤
、紫外線吸収剤、吸収促進剤(エイゾン、プロピレング
リコールのモノエステル又はジエステル、グリセリンの
ジエステル又はトリエステル、オレイルアルコール、2
−ヘキシルデシルアルコール、ジメチルスルホキシド、
アルキル−N,N−ジアルキルアミノ酢酸エステル、ミ
リスチン酸イソプロピルなど)などを配合することがで
きる。In addition to the above-mentioned essential ingredients, the hair growth agent of the present invention contains substances commonly used in hair growth agents, such as humectants (brobylene glycol, glycerin, diglycerin, etc.), solvents (
Ethyl alcohol, isopropyl alcohol, 1,3-
butylene glycol, purified water, etc.), preservatives (paraben, benzoic acid, etc.), vitamins (vitamin A, vitamin B, vitamin C, vitamin D, vitamin E, etc.), oils (liquid paraffin, cetyl alcohol, stearyl alcohol, squalane) , white petrolatum, olive oil, etc.)
, fungicides [sulfur, chlorhexidine gluconate, chlorhexidine hydrochloride, isopropylmethylphenol, quaternary
grade ammonium salts (such as benzalkonium chloride)
, dequalinium chloride, hinokitiol, etc.], nonionic surfactants (polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, sorbitan fatty acid ester, glycerin monofatty acid ester, polyoxyethylene hydrogenated castor oil derivative, etc.), thickener (
polyvinylpyrrolidone, carboxymethylcellulose,
carboxyethyl cellulose, hydroxypropyl cellulose, carboxyvinyl polymer, etc.), pH adjusters (diisopropanolamine, citric acid, etc.), antioxidants (dibutylhydroxytoluene, sodium bisulfite, etc.), cooling agents (1-menthol, camphor, etc.) ) Peripheral vasodilators (tropherol acetate, benzyl nicotinate, schwertiamarin, capsicum extract, kabsaicin, etc.), local anesthetics (dibucaine hydrochloride, lidocaine hydrochloride, etc.), keratolytic agents (urea, salicylic acid, etc.), follicles Hormones (17β-estradiol, estrone, etc.), progesterone (progesterone, 17α-
hydroxyprogesterone, etc.), adrenocortical hormones (
dexamethasone acetate, hydrocortisone acetate, etc.)
Antihistamines (diphenhydramine hydrochloride, isothipendyl hydrochloride, etc.), antiandrogens (cyproterone acetate, 4-androsten-3-one-17β-carboxylic acid, etc.), fragrances, sequestering agents, ultraviolet absorbers, absorption enhancers ( Aison, monoester or diester of propylene glycol, diester or triester of glycerin, oleyl alcohol, 2
-hexyldecyl alcohol, dimethyl sulfoxide,
(alkyl-N,N-dialkylaminoacetic acid ester, isopropyl myristate, etc.) can be blended.
【0014】[0014]
【発明の効果】本発明により発毛効果が著しく高く、し
かも皮膚刺激性の低い発毛剤を提供することが可能とな
った。[Effects of the Invention] According to the present invention, it has become possible to provide a hair growth agent that has an extremely high hair growth effect and has low skin irritation.
【0015】[0015]
【実施例】以下、実施例及び試験例を挙げて本発明を具
体的に説明する。[Examples] The present invention will be specifically explained below with reference to Examples and Test Examples.
【0016】(実施例1)
成分
配合量ドデシルジメチルアミノ酢酸ベタイ
ン
2g酢酸ハイドロコーチゾン
0.2gグリセリン
5gジブチルヒドロキシトルエン
0.1gグルコン酸クロルヘキシジン
0.1gビタミンB6
0.5gポリオキシエチレンモノステ
アレート
1.0gメチルセルロース
0.2gグリチルリチン酸ジカリウム
0.2gトウガラシチンキ
0.1g精製水
全100g溶
媒に各成分を混和溶解することによりローションを調製
した。(Example 1) Ingredients
Blend amount Dodecyldimethylaminoacetic acid betaine
2g hydrocortisone acetate
0.2g glycerin
5g dibutylhydroxytoluene
0.1g chlorhexidine gluconate
0.1g vitamin B6
0.5g polyoxyethylene monostearate
1.0g methylcellulose
0.2g dipotassium glycyrrhizinate
0.2g chili pepper tincture
0.1g purified water
A lotion was prepared by mixing and dissolving each component in a total of 100 g of solvent.
【0017】(実施例2)
成分
配合量ヤシ油ジメチルアミノ酪酸ベタイン
2g塩化ベルベリン
2g1,3−ブチレングリコール
5g塩酸イソチベンジル
0.1g硫黄
3.0gエ
ストロン
0.00
08gエチルアルコール
20g精製水
全100g実施例1に準じてロ
ーションを調製した。(Example 2) Ingredients
Blend amount Coconut oil dimethylaminobutyric acid betaine
2g berberine chloride
2g 1,3-butylene glycol
5g isothibenzyl hydrochloride
0.1g sulfur
3.0g estrone
0.00
08g ethyl alcohol
20g purified water
Total 100g A lotion was prepared according to Example 1.
【0018】(実施例3)
成分
配合量ヤシ油ジメチルアミノ酢酸ベタイン
3gイブプロフェン
1gプロピレングリコール
3gデシル−N,N−ジメチル−
アミノアセテート
3gポリオキシエチレン硬化ヒマシ油
3g
イソプロピルアルコール
5
g精製水
全100g実施例1に準じてローションを調製した
。(Example 3) Ingredients
Composition Coconut oil dimethylaminoacetic acid betaine
3g ibuprofen
1g propylene glycol
3g Decyl-N,N-dimethyl-
amino acetate
3g polyoxyethylene hydrogenated castor oil
3g
Isopropyl alcohol
5
g Purified water
Total 100g A lotion was prepared according to Example 1.
【0019】(実施例4)
成分
配合量ヘキサデシルジメチルアミノ酪酸ベ
タイン
1gアラントイン
1gエチルアルコール
20gプロピレングリコール
5g精製水
全100g実施例1に準
してローションを調製した。(Example 4) Ingredients
Blend amount Hexadecyldimethylaminobutyric acid betaine
1g allantoin
1g ethyl alcohol
20g propylene glycol
5g purified water
A lotion was prepared according to Example 1, totaling 100 g.
【0020】(実施例5)
成分
配合量オクタデシルジメチルアミノ酢酸ベ
タイン 2.
5gシコニン
1gエタノール
2g精製水
全100g実施
例1に準じてローションを調製した。(Example 5) Ingredients
Blend amount Octadecyldimethylaminoacetic acid betaine 2.
5g Shikonin
1g ethanol
2g purified water
Total 100g A lotion was prepared according to Example 1.
【0021】(実施例6)
成分
配合量オクタデシルジメチルアミノ酪
酸ベタイン
2g羊毛ケラチン
1gビタミンEアセテート
0.2gグリチルレチン酸
0.2gグリセリンモノカプレート
1gスクワラン
5g流動バラフィ
ン
15g白色
ワセリン
3gポリオキシエチレン(20)ソルビタンモノス
テアレート 4g精製水
全100gスク
ワラン、流動パラフィン及び白色ワセリンからなる油相
に油溶性成分及び非イオン性界面活性剤を加温溶解し、
これにオクタデシルジメチルアミノ酪酸ベタイン及び水
溶性成分を加温溶解した水相を添加し、乳化、冷却しク
リームを調製した。(Example 6) Ingredients
Blend amount Octadecyldimethylaminobutyric acid betaine
2g wool keratin
1g vitamin E acetate
0.2g glycyrrhetinic acid
0.2g glycerin monocaprate
1g squalane
5g liquid paraffin
15g white petrolatum
3g polyoxyethylene (20) sorbitan monostearate 4g purified water
An oil-soluble component and a nonionic surfactant are dissolved by heating into an oil phase consisting of a total of 100 g of squalane, liquid paraffin, and white petrolatum,
To this was added an aqueous phase in which betaine octadecyldimethylaminobutyrate and water-soluble components were dissolved under heating, and the mixture was emulsified and cooled to prepare a cream.
【0022】(実施例7)
成分
配合量イコシルジメチルアミノ酢酸ベタイ
ン
1gコレステロール
0.5gスクワラン
8gステアリルアルコール
2gポリオキシエチレン
硬化ヒマシ油
5gポリオキシエチレンソルビ
タンモノステアレート
2g塩化ベンザルコニウム
0
.1g精製水
全100gスクワラン、ステアリルアルコール
からなる油相に油溶性成分及び非イオン性界面活性剤を
加温溶解し、イコシルジメチルアミノ酢酸ベタイン及び
水溶性成分を加温溶解した水相を添加し、乳化、冷却し
乳液を調製した。(Example 7) Ingredients
Blend amount icosyldimethylaminoacetic acid betaine
1g cholesterol
0.5g squalane
8g stearyl alcohol
2g polyoxyethylene hydrogenated castor oil
5g polyoxyethylene sorbitan monostearate
2g benzalkonium chloride
0
.. 1g purified water
Oil-soluble components and nonionic surfactants were dissolved by heating in an oil phase consisting of 100 g of squalane and stearyl alcohol, and an aqueous phase in which icosyldimethylaminoacetic acid betaine and water-soluble components were dissolved by heating was added to emulsify. It was cooled and a milky lotion was prepared.
【0023】(実施例8)
原液
成分
配合量ヘキサデシルジメチルアミノ酢
酸ベタイン
3gイプシロンアミノカプロン酸
2gスクワラン
2gステアリルアルコー
ル
0.2gポリオキシエチ
レン硬化ヒマシ油
1gポリオキシエチレ
ンソルビタンモノステアレート
0.5gパラベン
0.15g精製水
全100g充填剤
ジメチルエーテル
実施例7の乳液の製法に従い原液を調製し、下記の処方
で通常の充墳法によりエアゾール剤を製造した。
処方
原液 : 30重量%
充填剤 : 70重量%(Example 8) Stock solution components
Blend amount Hexadecyldimethylaminoacetic acid betaine
3g epsilon aminocaproic acid
2g squalane
2g stearyl alcohol
0.2g polyoxyethylene hydrogenated castor oil
1g polyoxyethylene sorbitan monostearate
0.5g paraben
0.15g purified water
A total of 100 g filler dimethyl ether A stock solution was prepared according to the emulsion manufacturing method of Example 7, and an aerosol was manufactured using the following formulation using a conventional filling method. Prescription stock solution: 30% by weight Filler: 70% by weight
【0024】(実施例9)
成分
配合量ドデシルジメチルアミノ酢酸ベ
タイン
2gセラミド
0.5gポリビニルピロリド
ン
3gカルボキシ
ビニルポリマー
0.5gパラベン
0.1
5g精製水
全100g精製水にドデシルジメチルアミノ
酢酸ベタイン、グリチルリチン酸ジカリウム及びバラベ
ンを溶解した後、ポリビニルピロリドン及びカルボキシ
ビニルポリマーを添加、溶解しゲルを調製した。(Example 9) Ingredients
Blend amount Dodecyldimethylaminoacetic acid betaine
2g ceramide
0.5g polyvinylpyrrolidone
3g carboxyvinyl polymer
0.5g paraben
0.1
5g purified water
After dissolving betaine dodecyldimethylaminoacetate, dipotassium glycyrrhizinate, and paraben in a total of 100 g of purified water, polyvinylpyrrolidone and carboxyvinyl polymer were added and dissolved to prepare a gel.
【0025】(試験例)発毛効果試験
アルキルカルボキシベタインの発毛効果試験は、C3H
マウス(雄,7週令)5匹を一群として用い、その背部
毛をバリカンで除毛し、その部位に1日1回、表1に示
した試料0.2mlを10日間塗布し、その後の発毛程
度を下記の6段階で肉眼により評価した。
0:発毛が認められない
1:わずかな発毛が認められる
2:硬毛が生えている
3:硬毛が除毛部位の50%に生えている4:硬毛が除
毛部位の75%に生えている5:硬毛が除毛部位の10
0%に生えているまた、対照として試料を塗布しない群
についても同様に評価した。試料塗布開始後42日後の
結果を評価点の平均値で表2に示す。(Test Example) Hair Growth Effect Test Hair growth effect test of alkylcarboxybetaine was carried out using C3H
Using a group of 5 mice (male, 7 weeks old), their back hair was removed with clippers, and 0.2 ml of the sample shown in Table 1 was applied to the site once a day for 10 days. The degree of hair growth was visually evaluated in the following 6 grades. 0: No hair growth observed 1: Slight hair growth observed 2: Terminal hair growing 3: Terminal hair growing in 50% of the hair removal area 4: Terminal hair growing in 75% of the hair removal area 5%: Terminal hair is the hair removal site 10%
In addition, a group in which no sample was applied as a control was similarly evaluated. The results 42 days after the start of sample application are shown in Table 2 as the average value of the evaluation points.
【0026】[0026]
【表1】[Table 1]
【0027】[0027]
【表2】[Table 2]
Claims (1)
炭化水素の1価の基を示し、R2及びR3は水素原子又
は低級アルキル基を示し、Aは「メチル基又は水酸基」
で置換されていてもよい炭素原子数1〜3のアルキレン
基を示す。)で表される化合物又はその塩及び刺激緩和
剤を配合した発毛剤。Claim 1: Formula [Formula 1] (In Formula 1, R1 represents a monovalent group of saturated or unsaturated hydrocarbon having 6 to 26 carbon atoms, and R2 and R3 represent a hydrogen atom or a lower alkyl group) , A is "methyl group or hydroxyl group"
represents an alkylene group having 1 to 3 carbon atoms which may be substituted with ) or a salt thereof and an irritation reliever.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3094685A JPH04234804A (en) | 1990-02-13 | 1991-01-30 | Hair restorer |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2-31737 | 1990-02-13 | ||
JP3173790 | 1990-02-13 | ||
JP2-79798 | 1990-03-28 | ||
JP7979890 | 1990-03-28 | ||
JP3094685A JPH04234804A (en) | 1990-02-13 | 1991-01-30 | Hair restorer |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04234804A true JPH04234804A (en) | 1992-08-24 |
Family
ID=27287444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3094685A Pending JPH04234804A (en) | 1990-02-13 | 1991-01-30 | Hair restorer |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04234804A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06135821A (en) * | 1992-10-30 | 1994-05-17 | Kanebo Ltd | Hair tonic |
FR2709952A1 (en) * | 1993-09-15 | 1995-03-24 | Betourne Michel | Use of an ammonium salt of 18 beta -glycyrrhetinic acid for its biostimulatory action on hair growth |
JPH0853327A (en) * | 1994-06-10 | 1996-02-27 | Toshihiro Matsumoto | Hair tonic composed of allantoin or its derivative |
US6183742B1 (en) * | 1992-07-13 | 2001-02-06 | Nika Health Products, Limited | Applications of lysozyme dimer |
-
1991
- 1991-01-30 JP JP3094685A patent/JPH04234804A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6183742B1 (en) * | 1992-07-13 | 2001-02-06 | Nika Health Products, Limited | Applications of lysozyme dimer |
JPH06135821A (en) * | 1992-10-30 | 1994-05-17 | Kanebo Ltd | Hair tonic |
FR2709952A1 (en) * | 1993-09-15 | 1995-03-24 | Betourne Michel | Use of an ammonium salt of 18 beta -glycyrrhetinic acid for its biostimulatory action on hair growth |
JPH0853327A (en) * | 1994-06-10 | 1996-02-27 | Toshihiro Matsumoto | Hair tonic composed of allantoin or its derivative |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2814085B2 (en) | Hair restoration | |
PT1562531E (en) | Topical skin care composition | |
JPH07316023A (en) | Hair tonic | |
JPH08277209A (en) | Revitalizing hair tonic | |
JP2001519822A (en) | Composition containing antibacterial / antifungal agent and phospholipid | |
JP2733980B2 (en) | Hair restoration composition | |
KR910010018B1 (en) | Hair tonic | |
JPH04234804A (en) | Hair restorer | |
JP2021004184A (en) | Method of stabilizing allantoin and/or derivative thereof | |
JP3607709B2 (en) | Skin moisturizer | |
JP2969866B2 (en) | Hair growth agent | |
JP3568983B2 (en) | Hair restorer | |
CA2096971A1 (en) | Use of alkanamidoammonium compounds | |
CA2075502A1 (en) | Use of alkanamidocarboxybetaines | |
JP3314785B2 (en) | Minoxidil-containing hair restorer | |
KR100336005B1 (en) | Wool composition | |
JPH04120011A (en) | Hair growing agent | |
JP7467037B2 (en) | External Composition | |
JPH04159207A (en) | Hair-producing agent | |
JPH07206647A (en) | Hair tonic | |
JPH05139936A (en) | Hair producing agent | |
JP2600794B2 (en) | Hair growth agent | |
JP3529117B2 (en) | Hair restoration composition | |
JP2814090B2 (en) | Hair restoration | |
JP2000119197A (en) | Local treating preparation |